Condition: Atrial Fibrillation · Stroke · Sponsor: China National Center for Cardiovascular Diseases
This study is aimed to validate the existing stroke risk stratification model for patients with atrial fibrillation (AF) (CHA2DS2-VASc Score, CHADS2 Score, ATRIA score, ABC score, etc.) and establish a new stroke risk assessment model using a nationwide AF -specific registry in China.
This description comes directly from the study's public registry record.
Zhe Zheng, MD, PhD · +86-010-88396051 · zhengzhe@fuwai.com
Shuo Yuan, MD · yuanshuo@fuwai.com
Always discuss trial participation with your own doctor first.
| Fuwai Hospital, CAMS & PUMC | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05598632